Metz LM - Search Results

1

The Canadian Prospective Cohort Study to understand progression in multiple sclerosis: baseline characteristics.

Oh J, Arbour N, Giuliani F, Guenette M, Kolind S, Lynd L, Marrie RA, Metz LM, Prat A, Schabas A, Smyth P, Tam R, Traboulsee A, Yong VW, Patten SB. Oh J, et al. Among authors: metz lm. Ther Adv Neurol Disord. 2024 Sep 12;17:17562864241273045. doi: 10.1177/17562864241273045. eCollection 2024. Ther Adv Neurol Disord. 2024. PMID: 39282637 Free PMC article.

2

Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis.

Brundula V, Rewcastle NB, Metz LM, Bernard CC, Yong VW. Brundula V, et al. Among authors: metz lm. Brain. 2002 Jun;125(Pt 6):1297-308. doi: 10.1093/brain/awf133. Brain. 2002. PMID: 12023318

3

Interferon beta1a and depression in secondary progressive MS: data from the SPECTRIMS Trial.

Patten SB, Metz LM; SPECTRIMS Study Group. Patten SB, et al. Among authors: metz lm. Neurology. 2002 Sep 10;59(5):744-6. doi: 10.1212/wnl.59.5.744. Neurology. 2002. PMID: 12221168 Clinical Trial.

4

Hopelessness ratings in relapsing-remitting and secondary progressive multiple sclerosis.

Patten SB, Metz LM. Patten SB, et al. Among authors: metz lm. Int J Psychiatry Med. 2002;32(2):155-65. doi: 10.2190/2G2N-WE19-NM47-JNY8. Int J Psychiatry Med. 2002. PMID: 12269596 Clinical Trial.

5

Major depressive disorder and health care costs in multiple sclerosis.

Patten SB, Jacobs P, Petcu R, Reimer MA, Metz LM. Patten SB, et al. Among authors: metz lm. Int J Psychiatry Med. 2002;32(2):167-78. doi: 10.2190/K05D-XER3-WT4Y-FDQV. Int J Psychiatry Med. 2002. PMID: 12269597

6

Depressive symptoms in a treated multiple sclerosis cohort.

Patten SB, Fridhandler S, Beck CA, Metz LM. Patten SB, et al. Among authors: metz lm. Mult Scler. 2003 Dec;9(6):616-20. doi: 10.1191/1352458503ms960oa. Mult Scler. 2003. PMID: 14664476

7

Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.

Metz LM, Zhang Y, Yeung M, Patry DG, Bell RB, Stoian CA, Yong VW, Patten SB, Duquette P, Antel JP, Mitchell JR. Metz LM, et al. Ann Neurol. 2004 May;55(5):756. doi: 10.1002/ana.20111. Ann Neurol. 2004. PMID: 15122721 No abstract available.

8

The promise of minocycline in neurology.

Yong VW, Wells J, Giuliani F, Casha S, Power C, Metz LM. Yong VW, et al. Among authors: metz lm. Lancet Neurol. 2004 Dec;3(12):744-51. doi: 10.1016/S1474-4422(04)00937-8. Lancet Neurol. 2004. PMID: 15556807 Review.

9

Additive effect of the combination of glatiramer acetate and minocycline in a model of MS.

Giuliani F, Metz LM, Wilson T, Fan Y, Bar-Or A, Yong VW. Giuliani F, et al. Among authors: metz lm. J Neuroimmunol. 2005 Jan;158(1-2):213-21. doi: 10.1016/j.jneuroim.2004.09.006. J Neuroimmunol. 2005. PMID: 15589056

10

The association of depression with disease course in multiple sclerosis.

Zabad RK, Patten SB, Metz LM. Zabad RK, et al. Among authors: metz lm. Neurology. 2005 Jan 25;64(2):359-60. doi: 10.1212/01.WNL.0000149760.64921.AA. Neurology. 2005. PMID: 15668442

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters